Cited by 244Neurotransmitter Receptor Influence on BehaviorGenetic Associations and EpidemiologySchizophrenia research and treatment

BDNF variation and mood disorders, a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects

Jiang, Xueying, Xu, Ke, Hoberman, Joelle, Tian, Feng, Marko, Aimee J, Waheed, Juwaria F, Harris, Claudia R, Marini, Ann M +2 more·2005·Neuropsychopharmacology

Abstract

The brain-derived neurotrophic factor (BDNF) gene is critical for neuronal function and survival, and is likely to be important in psychiatric disorders. In this study, we used single-nucleotide polymorphism (SNP) discovery, functional analyses, and genetic association studies to better understand the potential role of BDNF sequence variation in behavior. Screening 480 unrelated individuals for SNPs and genotyping was performed in US Caucasian, American Indian, and African American populations. Lifetime DSM-III-R psychiatric diagnoses were assigned and the Tridimensional Personality Questionnaire (TPQ) was administered to measure anxious temperament (harm avoidance (HA)) and novelty seeking (NS). A novel SNP (-281 C>A) in promoter 1 was discovered that had decreased DNA binding in vitro and decreased basal reporter gene activity in transfected rat hippocampal neurons. The frequency of the -281 A allele was 0.03 in a Caucasian sample, but was virtually absent in other populations. Association analyses in a community-based sample showed that individuals with the -281 A allele (13 heterozygotes) had lower TPQ HA (F=4.8, p<0.05). In contrast, the Met 66 allele was associated with increased HA (F=4.1, p=0.02) and was most abundant in individuals with both anxiety disorders and major depression (p<0.05). Among the Val66Val homozygotes, individuals who were -281 CA heterozygotes had significantly lower HA than the -281 CC homozygotes (p<0.01). Our results suggest that in this population, the low activity -281 A allele may be protective against anxiety and psychiatric morbidity, whereas Met 66 may be a risk allele.

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300703

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jiang, X., Xu, K., Hoberman, J., Tian, F., Marko, A. J., Waheed, J. F., Harris, C. R., Marini, A. M., Enoch, M.-A., & Lipsky, R. H.
Affiliations
  • National Institutes of Health (US)
  • Uniformed Services University of the Health Sciences (US)
Corresponding author
Lipsky, Robert H
Venue
Neuropsychopharmacology
Published
2005-03-16
Volume
30
Issue
7
Pages
1353-1361
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2019522971
Cited by
244
References
45
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 2 · 2020: 6 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 12 · 2015: 15 · 2014: 12 · 2013: 16 · 2012: 17
FWCI
9.28
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Alcohol Abuse and Alcoholism (Z01AA000325, Z01-AA00325)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
brain-derived neurotrophic factor, BDNF gene, promoter polymorphism, BDNF Val66Met polymorphism, anxiety disorders, harm avoidance, novelty seeking, major depressive disorder, mood disorders, genetic association, DNA binding, risk alleles, protective alleles, personality traits
MeSH terms
Adult, Animals, Anxiety, Cells, Cultured, Embryo, Mammalian, Female, Gene Frequency, Genotype, Hippocampus, Humans, Male, Methionine, Middle Aged, Neurons, Personality Inventory, Promoter Regions, Genetic, RNA, Messenger, Transfection, Valine, Genetic Variation, Brain-Derived Neurotrophic Factor, Amino Acid Substitution, Mood Disorders, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Electrophoretic Mobility Shift Assay, Diagnostic and Statistical Manual of Mental Disorders, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review